Menu
Back to Journals » Journal of Hepatocellular Carcinoma » Volume 9
Original Research
Serum IGF-1 Scores and Clinical Outcomes in the Phase III IMbrave150 Study of Atezolizumab Plus Bevacizumab versus Sorafenib in Patients with Unresectable Hepatocellular Carcinoma
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 4,405 | Dovepress* | 4,038+ | 175 | 4,213 | |
| PubMed Central* | 367 | 143 | 510 | ||
| Totals | 4,405 | 318 | 4,723 | ||
| *Since 11 October 2022 | |||||
View citations on PubMed Central and Google Scholar